Walseng E - Search Results

1

Inclusion of an IgG1-Fc spacer abrogates efficacy of CD19 CAR T cells in a xenograft mouse model.

Almåsbak H, Walseng E, Kristian A, Myhre MR, Suso EM, Munthe LA, Andersen JT, Wang MY, Kvalheim G, Gaudernack G, Kyte JA. Almåsbak H, et al. Among authors: walseng e. Gene Ther. 2015 May;22(5):391-403. doi: 10.1038/gt.2015.4. Epub 2015 Feb 5. Gene Ther. 2015. PMID: 25652098

2

A TCR-based Chimeric Antigen Receptor.

Walseng E, Köksal H, Sektioglu IM, Fåne A, Skorstad G, Kvalheim G, Gaudernack G, Inderberg EM, Wälchli S. Walseng E, et al. Sci Rep. 2017 Sep 6;7(1):10713. doi: 10.1038/s41598-017-11126-y. Sci Rep. 2017. PMID: 28878363 Free PMC article.

3

Unpredicted phenotypes of two mutants of the TcR DMF5.

Tadesse FG, Mensali N, Fallang LE, Walseng E, Yang W, Olweus J, Wälchli S. Tadesse FG, et al. Among authors: walseng e. J Immunol Methods. 2015 Oct;425:37-44. doi: 10.1016/j.jim.2015.06.006. Epub 2015 Jun 14. J Immunol Methods. 2015. PMID: 26079729

4

Soluble T-cell receptors produced in human cells for targeted delivery.

Walseng E, Wälchli S, Fallang LE, Yang W, Vefferstad A, Areffard A, Olweus J. Walseng E, et al. PLoS One. 2015 Apr 13;10(4):e0119559. doi: 10.1371/journal.pone.0119559. eCollection 2015. PLoS One. 2015. PMID: 25875651 Free PMC article.

5

Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates.

Nanna AR, Li X, Walseng E, Pedzisa L, Goydel RS, Hymel D, Burke TR Jr, Roush WR, Rader C. Nanna AR, et al. Among authors: walseng e. Nat Commun. 2017 Oct 24;8(1):1112. doi: 10.1038/s41467-017-01257-1. Nat Commun. 2017. PMID: 29062027 Free PMC article.

6

Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLA.

Mensali N, Ying F, Sheng VO, Yang W, Walseng E, Kumari S, Fallang LE, Kolstad A, Uckert W, Malmberg KJ, Wälchli S, Olweus J. Mensali N, et al. Among authors: walseng e. Oncoimmunology. 2016 Feb 18;5(5):e1138199. doi: 10.1080/2162402X.2016.1138199. eCollection 2016 May. Oncoimmunology. 2016. PMID: 27467957 Free PMC article.

7

Chemically Programmed Bispecific Antibodies in Diabody Format.

Walseng E, Nelson CG, Qi J, Nanna AR, Roush WR, Goswami RK, Sinha SC, Burke TR Jr, Rader C. Walseng E, et al. J Biol Chem. 2016 Sep 9;291(37):19661-73. doi: 10.1074/jbc.M116.745588. Epub 2016 Jul 21. J Biol Chem. 2016. PMID: 27445334 Free PMC article.

8

Monitoring Protein Endocytosis and Recycling Using FACS-Based Assays.

Walseng E, Roche PA. Walseng E, et al. Methods Mol Biol. 2019;1988:279-288. doi: 10.1007/978-1-4939-9450-2_20. Methods Mol Biol. 2019. PMID: 31147947 Free PMC article.

9

Ubiquitination by March-I prevents MHC class II recycling and promotes MHC class II turnover in antigen-presenting cells.

Cho KJ, Walseng E, Ishido S, Roche PA. Cho KJ, et al. Among authors: walseng e. Proc Natl Acad Sci U S A. 2015 Aug 18;112(33):10449-54. doi: 10.1073/pnas.1507981112. Epub 2015 Aug 3. Proc Natl Acad Sci U S A. 2015. PMID: 26240324 Free PMC article.

10

Major histocompatibility complex class II-peptide complexes internalize using a clathrin- and dynamin-independent endocytosis pathway.

Walseng E, Bakke O, Roche PA. Walseng E, et al. J Biol Chem. 2008 May 23;283(21):14717-27. doi: 10.1074/jbc.M801070200. Epub 2008 Mar 31. J Biol Chem. 2008. PMID: 18378669 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page